Skip to main content

Table 3 Clinicopathological features of the one-to-one nearest neighbor–matched cohort

From: Effect of preoperative PI-RADS assessment on pathological outcomes in patients who underwent radical prostatectomy

Variables

PI-RADS

(n = 161)

Non-PI-RADS (n = 161)

p

Preoperative

Age (year)*

66.02 (5.81)

65.82 (6.09)

0.765

 

PSA (ng/mL)

  

0.215

 

 ≤10

98 (60.9)

86 (53.4)

 
 

 >10

63 (39.1)

75 (46.6)

 
 

Clinical T stage

   
 

 cT1-2

154 (95.7)

154 (95.7)

1.000

 

 cT3

7 (4.3)

7 (4.3)

 
 

ISUP grade

  

0.457

 

 1

52 (32.3)

54 (33.5)

 
 

 2

47 (29.2)

38 (23.6)

 
 

 3

33 (20.5)

30 (18.6)

 
 

 ≥ 4

29 (18.0)

39 (24.2)

 
 

Surgical experience

  

0.718

 

 <100

109 (67.7)

113 (70.2)

 
 

 ≥100

52 (32.3)

48 (29.8)

 
 

Indication of suspicious lesions on MRI

156 (96.9)

132 (82.0)

< 0.001

Postoperative

Pathological T stage

  

0.001

 

 pT2

132 (82.0)

105 (65.2)

 
 

 pT3-4

29 (18.0)

56 (34.8)

 
 

Upstaging

25 (15.5)

50 (31.1)

0.002

 

PSM

50 (31.1)

62 (38.5)

0.198

  1. Note—Unless otherwise indicated, data are number (percentages). PSA = prostate-specific antigen; ISUP = international society of urological pathology; PSM = positive surgical margin; PI-RADS = Prostate Imaging-Reporting and Data System
  2. * Data are mean (standard deviation [SD])